Detalhe da pesquisa
1.
Prognostic value of interim FDG-PET in diffuse large cell lymphoma: results from the CALGB 50303 Clinical Trial.
Blood
; 135(25): 2224-2234, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32232481
2.
Is local review of positron emission tomography scans sufficient in diffuse large B-cell lymphoma clinical trials? A CALGB 50303 analysis.
Cancer Med
; 12(7): 8211-8217, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799072
3.
A QA Program for MRD Testing Demonstrates That Systematic Education Can Reduce Discordance Among Experienced Interpreters.
Cytometry B Clin Cytom
; 94(2): 239-249, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475275
4.
FDG-PET lymphoma demonstration project invitational workshop.
Acad Radiol
; 14(3): 330-9, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17307666
5.
The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications.
Clin Cancer Res
; 23(15): 3980-3993, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28428191
6.
Workshop on imaging science development for cancer prevention and preemption.
Cancer Biomark
; 3(1): 1-33, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17655039
7.
Chemoprevention strategies in the prostate: an overview.
Rev Urol
; 4(2): 69-77, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-16985658